Local microRNA delivery targets Palladin and prevents metastatic breast cancer
Author(s)
Gilam, Avital; Weissglas-Volkov, Daphna; Friedman, Eitan; Shomron, Noam; Osorio De Castro Conde, Joao; Artzi, Natalie; Oliva, Nuria; ... Show more Show less
DownloadLocal microRNA.pdf (4.849Mb)
PUBLISHER_CC
Publisher with Creative Commons License
Creative Commons Attribution
Terms of use
Metadata
Show full item recordAbstract
Metastasis is the primary cause for mortality in breast cancer. MicroRNAs, gene expression master regulators, constitute an attractive candidate to control metastasis. Here we show that breast cancer metastasis can be prevented by miR-96 or miR-182 treatment, and decipher the mechanism of action. We found that miR-96/miR-182 downregulate Palladin protein levels, thereby reducing breast cancer cell migration and invasion. A common SNP, rs1071738, at the miR-96/miR-182-binding site within the Palladin 3′-UTR abolishes miRNA:mRNA binding, thus diminishing Palladin regulation by these miRNAs. Regulation is successfully restored by applying complimentary miRNAs. A hydrogel-embedded, gold-nanoparticle-based delivery vehicle provides efficient local, selective, and sustained release of miR-96/miR-182, markedly suppressing metastasis in a breast cancer mouse model. Combined delivery of the miRNAs with a chemotherapy drug, cisplatin, enables significant primary tumour shrinkage and metastasis prevention. Our data corroborate the role of miRNAs in metastasis, and suggest miR-96/miR-182 delivery as a potential anti-metastatic drug.
Date issued
2016-09Department
Massachusetts Institute of Technology. Institute for Medical Engineering & ScienceJournal
Nature Communications
Publisher
Nature Publishing Group
Citation
Gilam, Avital et al. “Local microRNA Delivery Targets Palladin and Prevents Metastatic Breast Cancer.” Nature Communications 7 (2016): 12868.
Version: Final published version
ISSN
2041-1723